コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 chemical stimuli (signaling lipids, volatile anesthetics).
2 arlson comorbidity index, and treatment with anesthetics).
3 in, and myosin light chain as targets of the anesthetics.
4 are used clinically as analgesics and local anesthetics.
5 mmalian brain, are major targets for general anesthetics.
6 s had active pacemakers at the time of their anesthetics.
7 nctionally inhibited by isoflurane and other anesthetics.
8 are targeted by benzodiazepines and general anesthetics.
9 diverse experimental conditions and types of anesthetics.
10 esthetics is very similar to that of general anesthetics.
11 electronic structure of proteins by general anesthetics.
12 pressure, temperature, signaling lipids, and anesthetics.
13 ity profiles of membranes in the presence of anesthetics.
14 dditivity of the effect of general and local anesthetics.
15 tate and not by local specific action of the anesthetics.
16 lay a crucial role in the actions of general anesthetics.
17 ree the puzzling structural heterogeneity of anesthetics.
18 tional targets for some neurosteroid general anesthetics.
19 voiding emetogenic and hyperalgesic volatile anesthetics.
20 investigate molecular mechanisms of general anesthetics.
21 eus (CMT) are important targets for volatile anesthetics.
22 a variety of therapeutics, including general anesthetics.
23 ase C (PKC) activity is modulated by general anesthetics.
24 to maintain variable levels of resistance to anesthetics.
25 ntial and is the primary target for volatile anesthetics.
26 diagnostic in vitro testing) and to volatile anesthetics.
27 thal genetic condition triggered by volatile anesthetics.
28 changes with age are modulated by inhalation anesthetics.
29 oxicity caused by low and high-potency local anesthetics.
30 nd-gated ion channels are targets of general anesthetics.
31 the greater and lesser occipital nerves with anesthetics.
32 side effects associated with conventional IV anesthetics.
33 s system function and the actions of general anesthetics.
34 e fifth transmembrane domain (S5) in sensing anesthetics.
35 animals resistant to systemically delivered anesthetics.
36 at potentiates the effect of delivered local anesthetics.
37 biotics (49.6%), muscle relaxants, latex and anesthetics (15%), nonsteroidal anti-inflammatory drugs
38 ch helps explain how closely related inhaled anesthetics achieve specific actions and suggests strate
39 s targets and putative mechanisms of general anesthetics across biology and identify key substrates t
40 e review the behavioral endpoints of general anesthetics across species and propose the isolation of
42 e neuronal mechanisms through which volatile anesthetics act to produce unconsciousness remain obscur
44 Here we exploit the observation that pungent anesthetics activate mammalian but not Drosophila TRPA1.
46 US$ 13-30 per cases multiplied by 25 million anesthetics administered annually in the USA has the pot
48 general anesthetics, barbiturates, and local anesthetics all display the same effect on melting trans
49 eta3Met-227 in betaM1 established that these anesthetics also bind to a homologous site, most likely
51 et, since the molecular targets of many such anesthetics alter the model dynamics in a manner similar
53 to ischemia, reduced sensitivity to volatile anesthetics, altered perception of pain, and a depressio
55 tory, cytostatics, diuretics, beta blockers, anesthetics, analgesics, antiepileptics, antidepressants
57 r many therapeutic agents, including general anesthetics and benzodiazepines, which enhance receptor
58 , interindividual variations in responses to anesthetics and consequences of exposure to anesthetic d
59 randomized to receive a TAP block with local anesthetics and dexamethasone, PILA with dexamethasone,
60 get of allosteric modulators such as general anesthetics and ethanol and is a major locus for hyperek
63 ifier Kv1 channels to modulation by volatile anesthetics and highlight an arousal suppressing role of
64 dered much less cardiotoxic than other local anesthetics and is used commonly as infusions for intrac
65 "on-pathway" targets for anthracene general anesthetics and may also represent functional targets fo
66 xious and vasorelaxant properties of general anesthetics and may prove useful in understanding effect
67 nostic related groups codes, blood pressure, anesthetics and narcotics administered, surgical and ane
70 a broad range of chemically diverse general anesthetics and related nonanesthetics on lipid bilayer
71 Our structural analysis using photoactivable anesthetics and rigid docking simulation showed that iso
74 minimum alveolar concentrations of volatile anesthetics and subcutaneous lidocaine efficacy have bee
76 s review, we outline the history of volatile anesthetics and their effect on kidney function, briefly
78 other relevant channels sensitive to general anesthetics and, as shown here, to barbiturates, at clin
79 der typically triggered by potent inhalation anesthetics and/or the depolarizing muscle relaxant succ
80 a group of gases including anesthetics, non-anesthetics, and anesthetic/convulsants on tubulin dynam
82 sodium channels are inhibited by many local anesthetics, antiarrhythmics, and antiepileptic drugs.
83 terial hypertension) and is an off target of anesthetics, antiparkinsonian drugs, and selective serot
89 Cumulatively, this work demonstrates that anesthetics are capable of directly activating endogenou
90 been no empirical demonstration that general anesthetics are capable of functional quantum interactio
95 imal fMRI and neurovascular studies, however anesthetics are known to profoundly affect neural and va
102 se range of noxious and non-noxious volatile anesthetics, at clinically relevant concentrations, inhi
104 reasoning, and that exposure to two or more anesthetics before age 2 nearly doubles the risk for an
108 ne receptors (nAChRs) are targets of general anesthetics, but functional sensitivity to anesthetic in
109 ion channels (pLGICs) are targets of general anesthetics, but molecular mechanisms underlying anesthe
110 are modulated by halogenated inhaled general anesthetics, but the underlying molecular mechanisms are
111 tates induced by five classes of intravenous anesthetics by relating their behavioral and physiologic
113 generally associated with sedation, but some anesthetics can also increase brain and motor activity-a
114 ive techniques be developed so that existing anesthetics can be used with minimum risk of neurotoxic
115 e lines of evidence demonstrate that general anesthetics can co-opt the neural circuits regulating ar
116 first experimental evidence that halogenated anesthetics can directly undergo quantum interaction mec
117 future studies to further determine whether anesthetics can induce behavioral hyperactivity via incr
118 es indicate that early postnatal exposure to anesthetics can lead to lasting deficits in learning and
121 Exposure of young animals to commonly used anesthetics causes neurotoxicity including impaired neur
123 en considerable focus on the hypothesis that anesthetics co-opt the neural mechanisms regulating slee
124 nding of the mechanisms of action of general anesthetics, coincident with progress in structural biol
125 ic regional anesthesia (over 46,000 regional anesthetics) demonstrate overall safety and lack of majo
126 provide a survey of the effects of different anesthetics, demonstrating that short exposure to diethy
130 eceptor (NMDAR) antagonists are dissociative anesthetics, drugs of abuse, and are of therapeutic inte
131 an effective dose equivalent of inhalational anesthetics during surgery (derived from mean end-tidal
133 support therapeutic applications of volatile anesthetics during the intraoperative and postoperative
135 transplant patients underwent 118 subsequent anesthetics during which they received neostigmine and g
137 sia through intravenous delivery of volatile anesthetics, eliminating the need for the use of large a
138 d that the degree of potentiation by general anesthetics (etomidate, propofol, and isoflurane) was gr
140 many general anesthetics, including volatile anesthetics, etomidate, propofol, and barbiturates.
141 activation was not attenuated by intravenous anesthetics, except for a high concentration of propofol
142 ane, desflurane) and i.v. (propofol) general anesthetics excite peripheral sensory nerves to cause pa
149 to network function and suggest that general anesthetics - from single cells to complex brains - crea
150 rature supports the idea that common general anesthetics (GAs) cause long-term cognitive changes and
154 dine enhanced the efficacy of released local anesthetics, greatly increasing the number of triggerabl
157 for isoflurane and 10 muM for propofol; both anesthetics have a lower affinity for the allosteric sit
158 is randomized study, we examined if volatile anesthetics have an effect on acute graft injury and cli
159 lthough immunomodulatory effects of volatile anesthetics have been growingly appreciated, the molecul
167 the effects that n-alcohols and other liquid anesthetics have on the two-dimensional miscibility crit
168 modulators such as barbiturates and steroid anesthetics have provided insight into the modes of acti
171 the primary pharmacologic effect of general anesthetics in a behavioral phenotype we termed "optoane
172 , and therefore have implications for use of anesthetics in AD patients, pending human study confirma
173 ospective studies to demonstrate the role of anesthetics in brain protection if any as well as define
179 ss of intersubunit binding sites for general anesthetics in the alpha1beta3gamma2 GABAAR transmembran
183 The trend toward smaller doses of local anesthetics in ultrasound-guided regional anesthesia imp
186 receptors, are the targets for many general anesthetics, including volatile anesthetics, etomidate,
187 ies suggest that modern halogenated volatile anesthetics induce potent anti-inflammatory, antinecroti
188 ow that both noxious and non-noxious general anesthetics inhibit agonist-evoked transient receptor po
189 We recently observed that several n-alcohol anesthetics inhibit heterogeneity in plasma-membrane-der
191 uggest that halogenated inhalational general anesthetics interact with gates and pore regions of thes
193 derstanding of the mechanisms and effects of anesthetics is a critically important part of neuroscien
196 The subconjunctival anesthesia with local anesthetics is considered as a low-risk procedure allowi
197 he inhibition of K-Shaw2 channels by general anesthetics is governed by interactions between binding
199 etailed action mechanism of volatile general anesthetics is still unknown despite their effect has be
200 pentameric ion channels by alkylphenol-based anesthetics is sufficient to induce modulation of activi
201 Thus, the thermodynamic behavior of local anesthetics is very similar to that of general anestheti
202 e neuroprotective benefit of intra-operative anesthetics is widely described and routinely aimed to i
203 role of pore block inhibition by the general anesthetics isoflurane and propofol of the prokaryotic p
205 Our reporter assay showed that volatile anesthetics isoflurane and sevoflurane increased the act
207 concentration-response of TASK-3 to several anesthetics (isoflurane, desflurane, sevoflurane, haloth
208 In the process of developing safer general anesthetics, isomers of anesthetic ethers and barbiturat
210 uency discharges of excitable cells by local anesthetics (LA) is largely determined by drug-induced p
211 als comparing epidural analgesia (with local anesthetics, lasting for >/= 24 hours postoperatively) w
212 one, and methylprednisolone) and three local anesthetics (lidocaine, ropivacaine, and bupivacaine) we
213 a cream, and (iii) the analysis of the local anesthetics, lidocaine and prilocaine, in a gel and a cr
216 rmalities, raising substantial concerns that anesthetics may cause similar cell death in young childr
220 the renal protective properties of volatile anesthetics may provide clinically useful therapeutic in
222 on by aryl sulfonamides and by classic local anesthetics might show an interaction mediated by their
223 The structural mechanisms underlying how anesthetics modulate pLGIC function remain largely unkno
226 f a large variety of agents such as volatile anesthetics, neuroprotective agents, and antidepressants
228 ugs of abuse (methamphetamine and fentanyl), anesthetics, neurotoxins, the pesticide paraquat, and he
229 ate the effect of a group of gases including anesthetics, non-anesthetics, and anesthetic/convulsants
230 the pharmacological effects of commonly used anesthetics nor with methadone, naloxone, oxycodone, or
231 All mutations reduced the log(d) values for anesthetics occupying both abutting and nonabutting pock
236 understanding of the effect of inhalational anesthetics on fetal cardiac function and some insight i
237 A kinetic model of the effect of agonist and anesthetics on ligand-gated ion channels, developed in e
238 hat hexadecanol acts oppositely to n-alcohol anesthetics on membrane mixing and antagonizes ethanol-i
239 l evidence informing the distinct effects of anesthetics on metastasis of breast cancers through chan
245 study sets the foundation for the effect of anesthetics on TLR9 and will pave the way for future stu
248 n these data that sedation with inhalational anesthetics outside of the operating room may likewise h
249 GABA, allosteric ligands such as the general anesthetics pentobarbital and etomidate can activate the
251 sity functional theory, we show that general anesthetics perturb and extend the highest occupied mole
253 Furthermore, the results indicate that the anesthetics propofol and pentobarbital interact with par
254 asal activity with the allosterically acting anesthetics propofol, pentobarbital, or alfaxalone.
257 e cortex, and postconditioning with volatile anesthetics provides neuroprotective actions that depend
258 ects of several clinically utilized volatile anesthetics, recent studies suggest that modern halogena
261 de that the inhibition of K-Shaw2 by general anesthetics results from allosteric interactions between
264 ABA(A)Rs) are believed to be key targets for anesthetics, sleep-promoting drugs, neurosteroids, and a
265 inhibited by general anesthetics, suggesting anesthetics stabilize a closed channel state, but in ane
266 s work suggested that n-alcohols and inhaled anesthetics stabilize the closed state of the Shaw2 volt
268 hysiology measurements suggest that volatile anesthetics such as isoflurane inhibit NaV by stabilizin
269 l circuitry, it has also been suggested that anesthetics such as propofol induce loss of consciousnes
270 We demonstrated in the past that volatile anesthetics such as sevoflurane attenuate ischemia-reper
272 sults suggest that propofol and other common anesthetics, such as etomidate and ketamine, may target
273 tic pLGIC homologue, is inhibited by general anesthetics, suggesting anesthetics stabilize a closed c
274 ts were found using three different types of anesthetics, suggesting that they are caused by the netw
278 tylphenol, two structural analogs of general anesthetics that are hydrophobic but have no anesthetic
279 arbiturate, [(3)H]R-mTFD-MPAB, photoreactive anesthetics that bind with high selectivity to distinct
280 o explore the preclinical efficacy of common anesthetics that function by reducing the TXA-mediated i
282 ., anxiolytics, anticonvulsants, and general anesthetics) that act as positive allosteric modulators
283 channel function is activated by halogenated anesthetics through binding at a putative anesthetic-bin
284 ite or sites, and they suggest that volatile anesthetics, through perturbations at a single site, inc
289 inantly inherited disorder in which volatile anesthetics trigger aberrant Ca(2+) release in skeletal
290 nimize POCD in the choice and development of anesthetics used during surgeries for patients suffering
295 , which is sensitive to a variety of general anesthetics, we performed multiple molecular dynamics si
297 onstrated that essentially all commonly used anesthetics, when used alone or in combination, enhance
298 and scientific interest in developing local anesthetics with prolonged durations of effect from sing